Ambu A/S

Company Overview

Ambu was founded in 1937, specializing in developing, manufacturing, and marketing innovative medical products for use in hospitals, clinics, and emergency services. Ambu offers its products through three segments: Visualization, Anaesthesia, and Patient Monitoring & Diagnostic.

The company caters to the bronchoscopy market through the Visualization segment. This segment offers Endoscopes, Displaying units, Video laryngoscopes, and Airway tubes with integrated cameras. Ambu has established a strong presence in the single-use endoscopy market, including bronchoscopy, and conducts approximately 1.7 million procedures annually. The endoscopy market encompasses four primary areas: ENT, pulmonology, gastroenterology, and urology. Endoscopy in the pulmonology area is referred to as Bronchoscopy. Ambu made a significant impact on the single-use market with the introduction of the first flexible single-use bronchoscope in 2009. The company offers a robust portfolio of sterile and high-performing bronchoscope solutions that meet the clinical needs of operating rooms, intensive care units, and bronchoscopy suites. The company sold 719,000 units of Ambu aScope 4, RhinoLaryngo (310,000 units), and AmbuaScope 4 Cysto (409,000 units) during FY 2022.

The company has a global workforce of approximately 5,000 employees spread across over 20 countries, serves more than 100 countries, and impacts the lives of over 100 million patients.

Financial Highlights (FY 2023)

Company's Business Segments

• Endoscopy Solutions : This segment offers high quality, single-use solutions across four major endoscopy segments: pulmonology, ear-nose-throat (ENT), urology, and gastroenterology (GI).
• Anaesthesia : This segment majorly intended to facilitate the ventilation of patients.
• Patient Monitoring : This segment mainly covers electrodes used for measuring electrical signals to monitor and diagnose patients.